Synergy CHC Corp. Completes Successful $4.375 Million Offering
Today in a significant move, Synergy CHC Corp. (NASDAQ: SNYR), a leading player in consumer health and wellness, announced the successful closure of its latest underwritten public offering. This issuance saw 1,750,000 shares of common stock sold at a price of $2.50 each, bringing in gross proceeds of $4.375 million before accounting for costs such as underwriting fees.
Details of the Offering
Moreover, the company has also granted underwriters a 45-day option that allows them to purchase up to an additional 262,500 shares at the same public offering price, adjusted for underwriting fees. This strategic decision not only reinforces Synergy’s growth strategy but also offers financial flexibility moving forward.
Warrants Issued to Underwriters
As part of this offering, Synergy CHC Corp. has issued warrants to underwriters for the purchase of 52,500 shares of common stock. Should the over-allotment be utilized, the total could rise to 60,375 shares. These warrants are set to be exercisable starting from 180 days following the offering's closure and will be scheduled to expire in tranches over the next five years, ensuring continued support and alignment with the underwriting team.
Assistance from Financial Partners
Spearheading this public offering was Bancroft Capital, LLC, taking the lead as the sole book-running manager. They were well-supported by Lucosky Brookman LLP in legal matters. Additionally, Synergy received valuable legal representation from Nelson Mullins Riley & Scarborough LLP, with a dedicated team led by David Mannheim, Mike Bradshaw, Kaylen Loflin, and Kathryn Simons, ensuring all aspects of the offering were meticulously handled.
What This Means for Synergy CHC Corp.
With the closure of this public offering, Synergy CHC Corp. is poised to leverage the influx of capital for enhancing its market position. The funds raised will be crucial in advancing its initiatives in the consumer health domain, especially with regard to its flagship brands, FOCUSfactor and Flat Tummy.
Driving Growth and Market Penetration
FOCUSfactor, known for its clinically studied brain health supplement, continues to create waves in the market. With established links to major retailers such as Costco, Walmart, and Amazon, Synergy has set its sights on further expansion, looking at both domestic and international markets. Meanwhile, the brand Flat Tummy expands the company's offerings into women’s wellness, perfectly complementing Synergy’s portfolio.
Investor Opportunities and Expectations
This completion not only highlights the confidence in Synergy CHC Corp. from the investing community but is also a testament to the company's robust strategies in place for future growth. Investors and stakeholders alike can look forward to the potential for an uplift in market share as the company navigates through various distribution channels, enhancing its visibility and product accessibility.
Frequently Asked Questions
What is the significance of this offering for Synergy CHC Corp.?
This offering allows Synergy to secure necessary capital to boost its market presence and further develop its product lines, especially its leading brands.
Who managed the public offering for Synergy CHC Corp.?
Bancroft Capital, LLC acted as the sole book-running manager for this specific public offering.
What brands does Synergy CHC Corp. offer?
Synergy specializes in consumer health and wellness products, notably FOCUSfactor and Flat Tummy, targeting both brain health and women’s wellness.
How will the raised funds be utilized?
The capital raised will be directed towards expanding market penetration, enhancing distribution channels, and developing existing and new products.
When are the warrants expected to become exercisable?
The warrants issued to underwriters will be exercisable starting 180 days after the closing of the offering.
